Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
548330, 548332, A61K 31415, C07D23510
A compound of the general formula I: ##STR1## or a salt or solvate thereof, in which, R.sup.1 represents hydrogen or a lower alkyl group,
patent: 2663712 (1953-12-01), Tulagin
patent: 3528798 (1970-09-01), Pfeiffer
A. Beckett et al., J. Pharm. Pharmacol. 8, pp. 661-665 (1956).
P. Preston, Chem. Reviews, 74(3), p. 279-314 (1974).
R. Markwell, J.C.S. Chem. Commun., pp. 428-430 (1979).
R. Vinegar et al., Fed. Proc., 41, pp. 2588-2595 (1982).
V. Karsten et al., Anal. Biochem. 77, pp. 464-470 (1977).
B. Jakschik et al., Biochem. Biophys. Res. Comm., 95 pp. 103-110 (1980).
Lane, E. et al., J. Chem. Soc., 569 (1956).
Chemical Abstracts, 83:141692c (1975) [Flockhart, I. et al., Proc. Eur. Soc. Study Drug Toxic., 1973, 14, 36-43].
Chemical Abstracts, 100:133915g (1984) [Adamson, G. et al., Pestic. Sci. 1984, 15(1), 31-39].
Hofmann, K., Imidazole and its Derivatives, Part 1, Interscience, New York, 1953, p. 261.
Markwell Roger E.
Smith Stephen A.
Beecham Group p.l.c.
Haley, Jr. James F.
Schwartz Richard A.
Solomon Teresa L.
2-(fluoroalkyl)-benzimidazoles as inhibitors of 5-lipoxygenase does not yet have a rating. At this time, there are no reviews or comments for this patent.If you have personal experience with 2-(fluoroalkyl)-benzimidazoles as inhibitors of 5-lipoxygenase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-(fluoroalkyl)-benzimidazoles as inhibitors of 5-lipoxygenase will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2332700